Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Day One Biopharmaceuticals, Inc.

Clinical trials sponsored by Day One Biopharmaceuticals, Inc., explained in plain language.

Trials to join now! 2 Terminated 1

Targeted drug trial for Tough-to-Treat cancers halted

Disease control Terminated

This study tested an experimental drug called DAY101 (tovorafenib) in people aged 12 and older with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the drug could shrink or control tumors that have specific genetic changes. The trial …

Phase: PHASE2 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC